title: Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
abstract: Endorepellin, a processed fragment of perlecan protein core, possesses anti-angiogenic activity by antagonizing endothelial cells. Endorepellin contains three laminin G-like (LG) domains and binds simultaneously to vascular endothelial growth factor receptor 2 (VEGFR2) and α2β1 integrin, resulting in dual receptor antagonism. Treatment of endothelial cells with endorepellin inhibits transcription of VEGFA, the natural ligand for VEGFR2, attenuating the pro-survival and migratory activities of VEGFA/VEGFR2 signaling cascade. Here, we investigated the specific binding site of endorepellin within the ectodomain of VEGFR2. Full-length endorepellin was not capable of displacing VEGFA binding from VEGFR2 and LG3 domain alone did not bind VEGFR2. This suggested different binding mechanisms of the extracellular Ig domains of VEGFR2. Therefore, we hypothesized that endorepellin would bind through its proximal LG1/2 domains to VEGFR2 in a different region than VEGFA. Indeed, we found that LG1/2 did not bind Ig1-3, but did bind with high affinity to Ig3-5, distal to the known VEGFA binding site, i.e. Ig2-3. These results support a role for endorepellin as an allosteric inhibitor of VEGFR2. Moreover, we found that LG1/2 blocked the rapid VEGFA activation of VEGFR2 at Tyr1175 in endothelial cells. In contrast, LG1/2 did not result in actin cytoskeletal disassembly in endothelial cells whereas LG3 alone did induce cytoskeletal collapse. However, LG1/2 did inhibit VEGFA-dependent endothelial migration through fibrillar collagen I. These studies provide a mechanistic understanding of how the different LG domains of endorepellin signal in endothelial cells while serving as a template for protein design of receptor tyrosine kinase antagonists.
authors: Department of Pathology, Anatomy and Cell Biology, and the Cancer Cell Biology and Signaling, Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
authors: Chris D
authors: CD
authors: Willis
authors: Chiara
authors: C
authors: Poluzzi
authors: Maurizio
authors: M
authors: Mongiat
authors: Renato V
authors: RV
authors: Iozzo
mesh_terms: D008841:Actin Cytoskeleton; D000199:Actins / Q000378:metabolism; D000494:Allosteric Regulation; D020533:Angiogenesis Inhibitors / Q000378:metabolism; D001665:Binding Sites; D002465:Cell Movement; D003094:Collagen / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism*; D057809:HEK293 Cells; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D038982:Integrin alpha2beta1 / Q000378:metabolism; D018919:Neovascularization, Physiologic; D010446:Peptide Fragments / Q000378:metabolism* / Q000494:pharmacology; D010766:Phosphorylation; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D015533:Transcriptional Activation; D014162:Transfection; D014443:Tyrosine / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000235:genetics / Q000378:metabolism*
chemical_list: D000199:Actins; D020533:Angiogenesis Inhibitors; D019812:Heparan Sulfate Proteoglycans; D038982:Integrin alpha2beta1; D010446:Peptide Fragments; D011994:Recombinant Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C071927:perlecan; D014443:Tyrosine; D003094:Collagen; D040301:Vascular Endothelial Growth Factor Receptor-2
references: J Biol Chem. 2001 Jun 1;276(22):18688-94
references: 11278319
references: Biochemistry. 2010 Jul 6;49(26):5524-32
references: 20507176
references: J Biol Chem. 2001 Mar 30;276(13):10263-71
references: 11148217
references: Microsc Res Tech. 2008 May;71(5):339-48
references: 18300285
references: J Cell Biol. 2009 May 18;185(4):743-54
references: 19433454
references: Mol Cancer Res. 2008 Jan;6(1):1-9
references: 18234958
references: Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):608-14
references: 12615671
references: J Biol Chem. 2006 Sep 8;281(36):26408-18
references: 16835231
references: J Biol Chem. 2000 Mar 10;275(10):7095-100
references: 10702276
references: Matrix Biol. 2012 May;31(4):234-45
references: 22421594
references: Glycobiology. 2007 Sep;17(9):897-905
references: 17442708
references: J Biol Chem. 2006 Feb 24;281(8):5178-87
references: 16269412
references: Mol Cell Biol. 1997 Apr;17(4):1938-46
references: 9121441
references: Chem Rev. 2005 Jul;105(7):2745-64
references: 16011323
references: Experientia. 1993 May 15;49(5):447-55
references: 8500599
references: J Biol Chem. 1997 Feb 21;272(8):5219-28
references: 9030592
references: Matrix Biol. 1999 Apr;18(2):163-78
references: 10372557
references: J Clin Invest. 1992 Mar;89(3):974-80
references: 1347297
references: J Biol Chem. 2006 Oct 13;281(41):30383-92
references: 16882656
references: Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1076-81
references: 15644447
references: Biochem J. 2011 Jul 15;437(2):169-83
references: 21711246
references: FASEB J. 2009 Oct;23(10):3368-76
references: 19528255
references: Lab Invest. 2010 Mar;90(3):374-82
references: 20084057
references: Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
references: 16633338
references: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6722-7
references: 10841569
references: Cancer Res. 1997 Jun 1;57(11):2130-6
references: 9187109
references: Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13612-7
references: 9391074
references: J Biol Chem. 2006 Feb 10;281(6):3711-21
references: 16326706
references: J Cell Biol. 1999 Nov 29;147(5):1109-22
references: 10579729
references: Cancer Res. 1994 Nov 15;54(22):5771-4
references: 7954396
references: Am J Pathol. 2002 Jan;160(1):195-204
references: 11786413
references: J Biol Chem. 2012 Dec 21;287(52):43543-56
references: 23060442
references: Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9939-44
references: 21622854
references: Invest Ophthalmol Vis Sci. 2012 Mar 09;53(3):1277-84
references: 22266517
references: Dev Dyn. 1997 Oct;210(2):130-45
references: 9337134
references: PLoS One. 2013;8(1):e53715
references: 23320101
references: Blood. 2009 Nov 26;114(23):4897-906
references: 19789387
references: Cancer Metastasis Rev. 1988 Apr;7(1):39-50
references: 3293831
references: Nat Struct Mol Biol. 2007 Mar;14(3):249-50
references: 17293873
references: Cancer Res. 2002 Oct 1;62(19):5580-9
references: 12359771
references: Cell. 2012 Feb 3;148(3):399-408
references: 22304911
references: J Biol Chem. 2003 Oct 3;278(40):38113-6
references: 12900424
references: Cancer Res. 2012 Apr 15;72(8):1909-14
references: 22508695
references: J Biol Chem. 2003 Aug 15;278(33):30516-24
references: 12788934
references: J Biol Chem. 2008 Oct 3;283(40):27220-9
references: 18658137
references: Nature. 2005 Dec 15;438(7070):932-6
references: 16355210
references: J Biol Chem. 1996 Apr 26;271(17):10079-86
references: 8626565
references: Nature. 2010 Dec 16;468(7326):968-72
references: 21107320
references: J Clin Invest. 2001 Aug;108(3):349-55
references: 11489925
references: J Cell Mol Med. 2011 May;15(5):1013-31
references: 21155971
references: Cancer Cell. 2005 Oct;8(4):299-309
references: 16226705
references: Biochemistry. 2008 Oct 28;47(43):11174-83
references: 18826258
references: J Natl Cancer Inst. 2006 Nov 15;98(22):1634-46
references: 17105986
references: Am J Pathol. 2009 Sep;175(3):1338-47
references: 19700757
references: J Biol Chem. 2011 Jul 22;286(29):25947-62
references: 21596751
references: Cell. 1997 Nov 28;91(5):695-704
references: 9393862
references: J Biol Chem. 2003 Feb 7;278(6):4238-49
references: 12435733
references: Nat Rev Mol Cell Biol. 2005 Aug;6(8):646-56
references: 16064139
references: Sci Transl Med. 2011 Jan 19;3(66):66ra5
references: 21248315
references: Curr Opin Hematol. 2008 May;15(3):235-42
references: 18391791
references: J Cell Biol. 2008 Apr 21;181(2):381-94
references: 18426981
references: J Biol Chem. 1997 Dec 19;272(51):32521-7
references: 9405464
references: Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14067-72
references: 21825147
references: Matrix Biol. 2010 Jan;29(1):63-73
references: 19788922
references: Angiogenesis. 1999;3(2):159-66
references: 14517433
references: Blood. 2007 May 1;109(9):3745-8
references: 17197432
references: J Biol Chem. 2000 Aug 18;275(33):25742-50
references: 10818109
references: Circ Res. 2002 Jul 26;91(2):158-64
references: 12142349
references: Exp Cell Res. 2006 Mar 10;312(5):594-607
references: 16376330
references: Cell. 1994 Dec 16;79(6):1005-13
references: 7528102
references: Cell. 2003 Jul 25;114(2):171-80
references: 12887919
references: J Cell Biol. 2004 Jul 5;166(1):97-109
references: 15240572
references: Trends Cell Biol. 2005 Jan;15(1):52-60
references: 15653078
references: J Biol Chem. 1994 Oct 28;269(43):26988-95
references: 7929439
references: J Histochem Cytochem. 1995 Sep;43(9):955-63
references: 7543915
references: Circ Res. 2008 Aug 1;103(3):289-97
references: 18583708
references: J Clin Invest. 1998 Oct 15;102(8):1599-608
references: 9788974
references: J Biol Chem. 2002 Aug 2;277(31):27872-9
references: 12029087
references: J Biol Chem. 2005 Feb 25;280(8):7080-7
references: 15591058
references: Matrix Biol. 2009 Jun;28(5):284-91
references: 19422911
references: J Histochem Cytochem. 1994 Feb;42(2):239-49
references: 7507142
references: FEBS J. 2010 Oct;277(19):3864-75
references: 20840584
references: BMC Biochem. 2010 Nov 03;11:43
references: 21047416
references: Mol Cells. 2009 May 31;27(5):503-13
references: 19466598
references: Cell Signal. 2007 Oct;19(10):2003-12
references: 17658244